$2.48 Billion is the total value of Alphabet Inc.'s 37 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 22.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OSCR | New | Oscar Health Inccl a | $646,273,000 | – | 24,042,864 | +100.0% | 26.05% | – |
| LYFT | Sell | Lyft Inc | $405,678,000 | -28.6% | 6,420,985 | -44.5% | 16.36% | -40.0% |
| DXCM | Dexcom Inc | $289,554,000 | -2.8% | 805,681 | 0.0% | 11.67% | -18.3% | |
| DM | Desktop Metal Inc. | $213,106,000 | -13.4% | 14,302,438 | 0.0% | 8.59% | -27.2% | |
| RCUS | Sell | Arcus Biosciences Inc | $132,632,000 | +1.2% | 4,723,348 | -6.5% | 5.35% | -15.0% |
| ABNB | Airbnb Inc | $129,981,000 | +28.0% | 691,612 | 0.0% | 5.24% | +7.6% | |
| UPST | Upstart Hldgs Inc | $107,266,000 | +216.2% | 832,423 | 0.0% | 4.32% | +165.8% | |
| SANA | New | Sana Biotechnology Inc | $94,134,000 | – | 2,812,500 | +100.0% | 3.80% | – |
| RLAY | Sell | Relay Therapeutics Inc | $54,222,000 | -27.6% | 1,568,486 | -12.9% | 2.19% | -39.1% |
| WORK | Slack Technologies Inc. | $52,810,000 | -3.8% | 1,299,771 | 0.0% | 2.13% | -19.2% | |
| BEAM | Sell | Beam Therapeutics Inc | $51,289,000 | -5.3% | 640,792 | -3.5% | 2.07% | -20.5% |
| KRON | Kronos Bio Inc | $42,097,000 | -2.0% | 1,438,232 | 0.0% | 1.70% | -17.7% | |
| MGTA | Magenta Therapeutics Inc | $39,535,000 | +51.0% | 3,339,138 | 0.0% | 1.59% | +26.9% | |
| CLOV | New | Clover Health Investments Co | $31,100,000 | – | 4,113,742 | +100.0% | 1.25% | – |
| OPEN | Opendoor Technologies Inc | $26,509,000 | -6.8% | 1,250,997 | 0.0% | 1.07% | -21.6% | |
| DBTX | New | Decibel Therapeutics Inc | $18,588,000 | – | 1,636,258 | +100.0% | 0.75% | – |
| RAPT | RAPT Therapeutics Inc | $18,454,000 | +12.4% | 831,254 | 0.0% | 0.74% | -5.6% | |
| IDYA | Ideaya Biosciences Inc | $17,700,000 | +67.9% | 753,187 | 0.0% | 0.71% | +41.1% | |
| LMND | Sell | Lemonade Inc | $16,549,000 | -83.6% | 177,698 | -78.5% | 0.67% | -86.2% |
| SPRO | Spero Therapeutics Inc | $13,100,000 | -24.1% | 889,979 | 0.0% | 0.53% | -36.2% | |
| TSHA | Taysha Gene Therapies Inc | $13,010,000 | -23.5% | 640,882 | 0.0% | 0.52% | -35.8% | |
| SQZ | SQZ Biotechnologies Co | $11,373,000 | -52.8% | 831,389 | 0.0% | 0.46% | -60.4% | |
| EVLO | Evelo Biosciences Inc | $11,347,000 | -11.5% | 1,060,495 | 0.0% | 0.46% | -25.7% | |
| FULC | Fulcrum Therapeutics Inc | $7,988,000 | +0.6% | 678,141 | 0.0% | 0.32% | -15.5% | |
| CRTX | Cortexyme Inc | $6,814,000 | +29.7% | 189,122 | 0.0% | 0.28% | +9.1% | |
| FHTX | Foghorn Therapeutics Inc | $6,602,000 | -35.0% | 500,901 | 0.0% | 0.27% | -45.4% | |
| CRWD | Crowdstrike Hldgs Inccl a | $5,661,000 | -13.8% | 31,020 | 0.0% | 0.23% | -27.6% | |
| NEWR | New Relic Inc | $5,603,000 | -6.0% | 91,132 | 0.0% | 0.23% | -21.0% | |
| AUTL | Autolus Therapeutics PLCspon ads | $4,001,000 | -35.9% | 698,262 | 0.0% | 0.16% | -46.2% | |
| ALEC | Alector Inc | $3,542,000 | +33.1% | 175,866 | 0.0% | 0.14% | +11.7% | |
| UBER | Uber Technologies Inc | $2,696,000 | +6.9% | 49,466 | 0.0% | 0.11% | -9.9% | |
| TWLO | Sell | Twilio Inccl a | $1,287,000 | -99.2% | 3,776 | -99.2% | 0.05% | -99.3% |
| DBX | Exit | Dropbox Inccl a | $0 | – | -13,033 | -100.0% | -0.01% | – |
| CLDR | Exit | Cloudera Inc | $0 | – | -427,710 | -100.0% | -0.28% | – |
| MWK | Exit | Mohawk Group Hldgs Inc | $0 | – | -586,327 | -100.0% | -0.48% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 8-K | 2024-04-25 |
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
| 4 | 2024-04-17 |
| 4 | 2024-04-15 |
| 144 | 2024-04-12 |
| 4 | 2024-04-04 |
| 144 | 2024-04-03 |
| 144 | 2024-04-03 |
| 4 | 2024-04-02 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.